Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Pharmaceutical Journal of Indonesia Hubungan Tingkat Pengetahuan Petugas Pengelola Obat dengan Tingkat Ketersediaan Obat Di Puskesmas Kota Malang
Dewi, Yunita Kristiana
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
The Anti-Inflammatory Benefit of Statins for Chronic Obstructive Pulmonary Disease (COPD): Review Article Dewi, Yunita Kristiana
Pharmaceutical Journal of Indonesia Vol 4, No 2 (2019)
Publisher : Brawijaya University

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is characterized by progressive, minimally reversible airflow limitation and systemic inflammation. Over the last 5 years, there have been  abundant studies proving the benefit of statin in COPD as an anti-inflammatory agent. So far, statin is mostly utilized in cardiology due to its effects of cholesterol reduction, immune system modulation, and anti oxidant. In point of fact, the effects of statin have proven to be advantageous when administered to COPD patients. The aim of this review is to examine the pharmacological mechanism of statins as anti-inflammatory drugs so that they can be considered as therapy in COPD.
The Anti-Inflammatory Benefit of Statins for Chronic Obstructive Pulmonary Disease (COPD): Review Article Dewi, Yunita Kristiana
Pharmaceutical Journal of Indonesia Vol 4, No 2 (2019)
Publisher : Brawijaya University

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is characterized by progressive, minimally reversible airflow limitation and systemic inflammation. Over the last 5 years, there have been  abundant studies proving the benefit of statin in COPD as an anti-inflammatory agent. So far, statin is mostly utilized in cardiology due to its effects of cholesterol reduction, immune system modulation, and anti oxidant. In point of fact, the effects of statin have proven to be advantageous when administered to COPD patients. The aim of this review is to examine the pharmacological mechanism of statins as anti-inflammatory drugs so that they can be considered as therapy in COPD.
Co-Authors